CA2425767A1 - Lipocalines - Google Patents
Lipocalines Download PDFInfo
- Publication number
- CA2425767A1 CA2425767A1 CA002425767A CA2425767A CA2425767A1 CA 2425767 A1 CA2425767 A1 CA 2425767A1 CA 002425767 A CA002425767 A CA 002425767A CA 2425767 A CA2425767 A CA 2425767A CA 2425767 A1 CA2425767 A1 CA 2425767A1
- Authority
- CA
- Canada
- Prior art keywords
- polynucleotide
- polypeptide
- lipoc
- antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
L'invention concerne des lipocalines (LIPOC) humaines et des polynucléotides identifiant et codant pour les lipocalines (LIPOC). L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes, et des antagonistes. L'invention concerne également des méthodes de diagnostic, de traitement, ou de prévention des troubles associés à l'expression aberrante des lipocalines (LIPOC).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24054100P | 2000-10-13 | 2000-10-13 | |
US60/240,541 | 2000-10-13 | ||
PCT/US2001/031942 WO2002031151A2 (fr) | 2000-10-13 | 2001-10-12 | Lipocalines |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2425767A1 true CA2425767A1 (fr) | 2002-04-18 |
Family
ID=22906956
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002425767A Abandoned CA2425767A1 (fr) | 2000-10-13 | 2001-10-12 | Lipocalines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1325128A2 (fr) |
JP (1) | JP2004528813A (fr) |
AU (1) | AU2001296831A1 (fr) |
CA (1) | CA2425767A1 (fr) |
WO (1) | WO2002031151A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0217402D0 (en) * | 2002-07-26 | 2002-09-04 | Roslin Inst Edinburgh | Multi-reporter gene model for toxicological screening |
GB0426650D0 (en) * | 2004-12-03 | 2005-01-05 | Univ Cardiff | Transgenic animals |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1009762A2 (fr) * | 1997-08-06 | 2000-06-21 | ZymoGenetics, Inc. | Homologues de lipocaline |
US20020137159A1 (en) * | 2000-08-31 | 2002-09-26 | Si Lok | Human phermone polypeptides |
-
2001
- 2001-10-12 EP EP01977737A patent/EP1325128A2/fr not_active Withdrawn
- 2001-10-12 AU AU2001296831A patent/AU2001296831A1/en not_active Abandoned
- 2001-10-12 WO PCT/US2001/031942 patent/WO2002031151A2/fr not_active Application Discontinuation
- 2001-10-12 CA CA002425767A patent/CA2425767A1/fr not_active Abandoned
- 2001-10-12 JP JP2002534519A patent/JP2004528813A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2001296831A1 (en) | 2002-04-22 |
WO2002031151A2 (fr) | 2002-04-18 |
JP2004528813A (ja) | 2004-09-24 |
EP1325128A2 (fr) | 2003-07-09 |
WO2002031151A3 (fr) | 2003-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20040048290A1 (en) | Aminoacyl trna synthetases | |
US20040018505A1 (en) | Aminoacyl trna synthetases | |
CA2431493A1 (fr) | Aminoacyl arnt synthetases | |
CA2408315A1 (fr) | Aminoacyl-arnt synthetases | |
US20050227277A1 (en) | Apoptosis proteins | |
WO2000070047A2 (fr) | Molecules completes exprimees dans des tissus humains | |
US20050048479A1 (en) | Adenylyl and guanylyl cyclases | |
US20020160950A1 (en) | Cytochrome P450 variant | |
EP1190050A2 (fr) | Proteines de regulateur de transcription humaines | |
WO2002004611A2 (fr) | Aminoacyl arnt synthetases | |
WO2002048362A2 (fr) | Proteines associees a l'embryogenese | |
CA2425767A1 (fr) | Lipocalines | |
WO2002046413A2 (fr) | Molecules pour la detection et le traitement de maladies | |
US20040043452A1 (en) | Embryogenesis associated proteins | |
CA2378989A1 (fr) | Proteines humaines de domaine lim | |
CA2402747A1 (fr) | Molecules associees a la proteine g | |
US20040033583A1 (en) | Isomerases | |
US20040101872A1 (en) | Lipocalins | |
EP1192250A2 (fr) | Proteines du metabolisme de l'arn | |
EP1265918A1 (fr) | Proteines de reponse immunitaire humaines | |
EP1477564A2 (fr) | Synthetases humaines | |
US20040096858A1 (en) | Adenylyl and guanylyl cyclases | |
US20040023251A1 (en) | Cell cycle proteins and mitosis-associated molecules | |
US20030208040A1 (en) | G-protein associated molecules | |
CA2417676A1 (fr) | Sequences pour l'integrine alpha-8 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |